Katherine Levy
Apr 14, 2011

Novartis to review US$600m global media business

GLOBAL - Novartis, the pharmaceutical giant, is gearing up to launch a review of its estimated US$600 million global media business.

Novatris currently works with incumbent MEC
Novatris currently works with incumbent MEC

WPP's MEC is the incumbent on the global business.

In 2008 Novartis consolidated its US media planning and buying into MEC after moving its business from sibling agency Mindshare in a global realignment.

Novartis, which is headquartered in Basel, Switzerland, has three other businesses called Pharmaceuticals, Vaccines and Diagnostics, and Sandoz Generics, a global supplier of generic medicines that are produced after a popular medicine's patent has expired.

This article was first published on campaignlive.co.uk.

Source:
Campaign Asia

Follow us

Top news, insights and analysis every weekday

Sign up for Campaign Bulletins

Related Articles

Just Published

Jan 29, 2026

Gemini 3 becomes the default model for AI Overviews

A pair of updates from Google see the tech giant attempt to gain a further foothold in the battle for AI-powered search supremacy.

Jan 29, 2026

Google criticised after blocking measurement ...

YouTube owner sent a 'cease and desist' letter to Barb and Kantar Media.

Jan 29, 2026

Inside Campaign Connect Indonesia: what matters to ...

Candid conversations on growth, AI and the cultural trade-offs of scaling brands, with more than 100 marketers in the room.

Jan 29, 2026

Meta hits $200 billion revenue milestone on ...

Meta reports double‑digit year-on-year revenue growth, with advertising once again accounting for almost all of the top line.